ACC 2013 Report – Ticagrelor has its largest effect in ACS patients with elevated troponin
Recent guidelines suggest that NSTEMI patients with elevated troponin levels are recommended for early invasive treatment, but a substantial proportion are still managed without an early invasive procedure.